Inotiv Inc
(NAS:NOTV)
$
5.03
0.84 (20.05%)
Market Cap: 161.03 Mil
Enterprise Value: 557.83 Mil
PE Ratio: 0
PB Ratio: 0.77
GF Score: 78/100 Inotiv Inc at UBS Global Healthcare Conference Transcript
May 24, 2022 / 11:45AM GMT
Release Date Price:
$13.41
(+2.05%)
John Newton Sourbeer
UBS Investment Bank, Research Division - Equity Research Associate
Hi, and welcome to day 2 of the UBS Global Healthcare Conference. I'm John Sourbeer. And I cover Life Sciences Tools and Pharma Services. I'm happy to start off the day here with Inotiv. We have Bob Leasure, President and CEO, and Beth Taylor, the CFO. Welcome.
Robert W. Leasure
Inotiv, Inc. - President, CEO & Director
Good morning.
John Newton Sourbeer
UBS Investment Bank, Research Division - Equity Research Associate
So I believe that you're going to start off with a presentation, and then we can go into some Q&A.
Robert W. Leasure
Inotiv, Inc. - President, CEO & Director
Yes, it's our first time to present at this conference. I thought we'd do a presentation briefly and then the Q&A if it is okay with you.
John Newton Sourbeer
UBS Investment Bank, Research Division - Equity Research Associate
Sounds great.
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot